InsidersTradesSigma
Egetis Therapeutics AB (publ): management transactions · Finland · FIN-FSA
FI:egetis-therapeutics-ab-publSE0003815604FI·FIN-FSAMcap 2.1Bn€
Browse the full management transaction log of Egetis Therapeutics AB (publ), a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Market capitalisation: €2.1bn. The latest transaction was disclosed on 15 May 2026 — Purchase. Among the most active insiders: Christian Sonesson. Every trade is openly available.
10
Insider Decl.
0
Thresholds
€52,213
8 ops.
Buy Volume
€162,487
2 ops.
Sell Volume
Financial data
Income statement
Revenue62.4 M€
Gross profit12.4 M€20% margin
Net income−342.5 M€-548.9% margin
Balance sheet & cash
Market cap2.11 Bn€
Total debt90.6 M€
Free Cash Flow−268.5 M€
Last declaration on 15 May 2026
Declarations10 total
Executives●Purchase3FIN-FSA
0529,761 shares0
Aktie
FI:A003Y632-1·
Ideal exit: 5 Feb 2027 (T+270)
Executives●Purchase7FIN-FSA
0264,880 shares0
Aktie
FI:A003Y653-1·
Ideal exit: 5 Feb 2027 (T+270)
Executives●Purchase7FIN-FSA
0264,880 shares0
Aktie
FI:A003Y615-1·
Ideal exit: 5 Feb 2027 (T+270)
Executives●Sale11FIN-FSA
SEK 91,386153,631 shares@ SEK 0.59480.0043% mcap100.0% of flow
Aktie
FI:A003Y582-1·
Executives●Sale15FIN-FSA
€71,101119,529 shares@ €0.59480.0034% mcap86.9% of flow
Aktie
FI:A003Y593-1·
Executives●Purchase21FIN-FSA
€21,05560,000 shares@ €0.35090.0010% mcap18.7% of flow
Aktie
FI:A003U276-2·
Ideal exit: 23 Aug 2026 (T+270)
Executives●Purchase8FIN-FSA
€10,75625,000 shares@ €0.43030.0005% mcap13.1% of flow
Aktie
FI:A003U284-1·
Ideal exit: 25 Aug 2026 (T+270)
Executives●Purchase15FIN-FSA
€6,50115,000 shares@ €0.43340.0003% mcap100.0% of flow
Aktie
FI:A003U244-2·
Ideal exit: 24 Aug 2026 (T+270)
Executives●Purchase15FIN-FSA
€8,92925,000 shares@ €0.35720.0004% mcap100.0% of flow
Aktie
FI:A003U240-1·
Ideal exit: 23 Aug 2026 (T+270)
Executives●Purchase15FIN-FSA
€4,97213,460 shares@ €0.36940.0002% mcap100.0% of flow
Aktie
FI:A003P637-1·
Ideal exit: 2 Mar 2026 (T+270)
10 of 10 declarations
